Antivirals for treatment of HCV infections
Harvoni
The FDA lists this product in 4 strengths and forms.
Composition
- Active ingredients
- LEDIPASVIR 33.75MG; SOFOSBUVIR 150MG/PACKET
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- LEDIPASVIR 33.75MG; SOFOSBUVIR 150MG/PACKET · PelletsThis page
- LEDIPASVIR 45MG; SOFOSBUVIR 200MG/PACKET · PelletsNDA212477-002 · Prescription
- LEDIPASVIR 90MG; SOFOSBUVIR 400MG · TabletNDA205834-001 · Prescription
- LEDIPASVIR 45MG; SOFOSBUVIR 200MG · TabletNDA205834-002 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA212477.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.